Japan industry group to examine clinical site cost discrepancies
Japanese industry group JPMA has opted for cloud-based tech to help it understand why the cost of running a trial in the country varies depending on the site involved.
Archives for August 31, 2015
AMRI boosts opiate API biz through tech transfer and supply deal with Saneca
AMRI has inked a deal with Slovakia’s Saneca Pharmaceuticals to bolster its opium-derived API portfolio.
BMS pays $125m to Promedior in second 'right-to-buy' option in fibrosis space
Bristol-Myers Squibb has acquired the rights to buy immunotherapy firm Promedior and could pay up to $1.25bn (€1.1bn) depending on the clinical development of its lead fibrosis product PRM-151.
Veterans suited to pharma says Texas A&M
Army training is ideal preparation for a biopharma career according to the US National Center for Therapeutics Manufacturing, which is seeking former military personnel interested in learning about bioprocessing.
Fareva buys Merck & Co API plant in France and outlines plan to invest €25m
Fareva has bought an API plant in France from Merck & Co. and outlined plans to turn it into a high-potency actives site.